Elizabeth Call, PsyD, formerly a clinical instructor in psychiatry at Harvard Medical School, is currently a sub-investigator and therapist on the FDA phase 3 trials for MDMA assisted psychotherapy for PTSD. She is in private practice in Cambridge and draws on Ketamine Assisted Psychotherapy, EMDR, IFS, Mindfulness and trauma-informed therapy as allies in healing. She has had a committed Buddhist meditation practice for over 30 years.
Elizabeth Call, PsyD, interned at McLean Hospital and is a former clinical instructor in psychiatry at Harvard Medical School. After graduate school, she was a staff psychologist on an inpatient forensic unit at MGH and joined the adult treatment team at Bessel van der Kolk’s Trauma Center. She is a licensed clinical psychologist, an EMDRIA approved consultant and is a certified therapist in IFS. She has an independent practice in Cambridge, MA, and specializes in trauma and loss with attention to spirituality, and accessing expanded states of consciousness in the service of healing. She is currently a sub-investigator and therapist on the FDA phase 3 trials for MDMA assisted psychotherapy for PTSD sponsored by MAPS. She is also trained in Ketamine Assisted Psychotherapy and has been incorporating it into her practice with traumatized patients since October, 2018.
Dr. Call has experience within the Zen and Vipassana traditions of meditation. She has meditated in uninterrupted silence for several traditional 3 month Vipassana retreats in Burma, India and the United States. She is committed to an active mindfulness practice in her work as a therapist. In addition, she co-founded Burma Border Projects, a non-profit organization that brings education, housing and mental health services to Burmese refugees in need.